nach oben

Erschienen in:

11.10.2017 | Diagnostic Neuroradiology

Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls

verfasst von: Ji Young Lee, Young-Jun Lee, Dong Woo Park, Yoonho Nam, Seung Hyun Kim, Jinseok Park, Young Seo Kim, Hyun Young Kim, Ki-Wook Oh

Erschienen in: Neuroradiology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to investigate the differences in motor cortex susceptibility among patients with amyotrophic lateral sclerosis (ALS), cerebrovascular disease (CVD), and healthy controls using quantitative susceptibility mapping (QSM).

Methods

We retrospectively reviewed 78 QSM images from 26 patients with ALS, 26 age- and sex-matched patients with CVD, and 26 healthy controls. A region of interest was drawn in the hand lobule of both the motor cortexes and subcortical white matter. The relative susceptibility (RS) of the motor cortex was obtained by subtracting the susceptibility of the subcortical white matter from that of the motor cortex. We compared the cortex_mean, cortex_max, subcortical white matter_mean, RS_mean, and RS_max values among the three groups using analysis of variance and Tukey’s post hoc test. Receiver operating characteristic (ROC) curve analysis was also performed.

Results

There were significant differences in the cortex_mean, cortex_max, RS_mean, and RS_max among the three groups, with higher values in patients with ALS (p = 0.01, p = 0.004, p < 0.001, and p < 0.001, respectively). Subcortical white matter_mean was significantly lower in patients with ALS compared with patients with CVD and healthy controls (p = 0.04). ROC curve analysis showed that the area under the curve of RS_mean was 0.70, the highest among the measured parameters.

Conclusion

Quantitative measurements of susceptibility of the motor cortex with QSM demonstrate its potential as an imaging biomarker in ALS patients.

Nur mit Berechtigung zugänglich

Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet (London, England) 377(9769):942–955. https://doi.org/10.1016/s0140-6736(10)61156-7 CrossRef

Duclos Y, Grapperon AM, Jouve E, Truillet R, Zemmour C, Verschueren A, Pouget J, Attarian S (2017) Motor-evoked potential gain is a helpful test for the detection of corticospinal tract dysfunction in amyotrophic lateral sclerosis. Clinical Neurophysiology : Official J Int Federation Clinical Neurophysiology 128(2):357–364. https://doi.org/10.1016/j.clinph.2016.12.015 CrossRef

Cirillo M, Esposito F, Tedeschi G, Caiazzo G, Sagnelli A, Piccirillo G, Conforti R, Tortora F, Monsurro MR, Cirillo S, Trojsi F (2012) Widespread microstructural white matter involvement in amyotrophic lateral sclerosis: a whole-brain DTI study. AJNR Am J Neuroradiol 33(6):1102–1108. https://doi.org/10.3174/ajnr.A2918 CrossRefPubMed

Furtula J, Johnsen B, Frandsen J, Rodell A, Christensen PB, Pugdahl K, Fuglsang-Frederiksen A (2013) Upper motor neuron involvement in amyotrophic lateral sclerosis evaluated by triple stimulation technique and diffusion tensor MRI. J Neurol 260(6):1535–1544. https://doi.org/10.1007/s00415-012-6824-8 CrossRefPubMed

Bruijn LI, Cleveland DW (1996) Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease. Neuropathol Appl Neurobiol 22(5):373–387CrossRefPubMed

Tefera TW, Borges K (2016) Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Front Neurosci 10:611. https://doi.org/10.3389/fnins.2016.00611 PubMed

Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762(11–12):1051–1067. https://doi.org/10.1016/j.bbadis.2006.03.008 CrossRefPubMed

Bowen BC, Pattany PM, Bradley WG, Murdoch JB, Rotta F, Younis AA, Duncan RC, Quencer RM (2000) MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 21(4):647–658PubMed

Kwan JY, Jeong SY, Van Gelderen P, Deng HX, Quezado MM, Danielian LE, Butman JA, Chen L, Bayat E, Russell J, Siddique T, Duyn JH, Rouault TA, Floeter MK (2012) Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 7(4):e35241. https://doi.org/10.1371/journal.pone.0035241 CrossRefPubMedPubMedCentral

10.

Sheelakumari R, Madhusoodanan M, Radhakrishnan A, Ranjith G, Thomas B (2016) A potential biomarker in amyotrophic lateral sclerosis: can assessment of brain iron deposition with SWI and corticospinal tract degeneration with DTI help? AJNR Am J Neuroradiol 37(2):252–258. https://doi.org/10.3174/ajnr.A4524 CrossRefPubMed

11.

Schweitzer AD, Liu T, Gupta A, Zheng K, Seedial S, Shtilbans A, Shahbazi M, Lange D, Wang Y, Tsiouris AJ (2015) Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. AJR Am J Roentgenol 204(5):1086–1092. https://doi.org/10.2214/ajr.14.13459 CrossRefPubMedPubMedCentral

12.

Liu C, Li W, Tong KA, Yeom KW, Kuzminski S (2015) Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J magnetic resonance imaging : JMRI 42(1):23–41. https://doi.org/10.1002/jmri.24768 CrossRefPubMed

13.

Azuma M, Hirai T, Yamada K, Yamashita S, Ando Y, Tateishi M, Iryo Y, Yoneda T, Kitajima M, Wang Y, Yamashita Y (2016) Lateral asymmetry and spatial difference of iron deposition in the substantia nigra of patients with Parkinson disease measured with quantitative susceptibility mapping. AJNR Am J Neuroradiol 37(5):782–788. https://doi.org/10.3174/ajnr.A4645 CrossRefPubMedPubMedCentral

14.

Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, Pei M, Pitt D, Wang Y (2014) Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 271(1):183–192. https://doi.org/10.1148/radiol.13130353 CrossRefPubMedPubMedCentral

15.

Moon Y, Han SH, Moon WJ (2016) Patterns of brain iron accumulation in vascular dementia and Alzheimer’s dementia using quantitative susceptibility mapping imaging. J Alzheimer's disease : JAD 51(3):737–745. https://doi.org/10.3233/JAD-151037 CrossRefPubMed

16.

Ogasawara A, Kakeda S, Watanabe K, Ide S, Ueda I, Murakami Y, Moriya J, Futatsuya K, Sato T, Nakayamada S, Saito K, Tanaka Y, Liu T, Wang Y, Korogi Y (2016) Quantitative susceptibility mapping in patients with systemic lupus erythematosus: detection of abnormalities in normal-appearing basal ganglia. Eur Radiol 26(4):1056–1063. https://doi.org/10.1007/s00330-015-3929-3 CrossRefPubMed

17.

Agosta F, Chio A, Cosottini M, De Stefano N, Falini A, Mascalchi M, Rocca MA, Silani V, Tedeschi G, Filippi M (2010) The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 31(10):1769–1777. https://doi.org/10.3174/ajnr.A2043 CrossRefPubMed

18.

Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 30(1):19–30. https://doi.org/10.3174/ajnr.A1400 CrossRefPubMed

19.

Langkammer C, Liu T, Khalil M, Enzinger C, Jehna M, Fuchs S, Fazekas F, Wang Y, Ropele S (2013) Quantitative susceptibility mapping in multiple sclerosis. Radiology 267(2):551–559. https://doi.org/10.1148/radiol.12120707 CrossRefPubMedPubMedCentral

20.

Langkammer C, Ropele S, Pirpamer L, Fazekas F, Schmidt R (2014) MRI for iron mapping in Alzheimer’s disease. Neurodegener Dis 13(2–3):189–191. https://doi.org/10.1159/000353756 PubMed

21.

Langkammer C, Schweser F, Krebs N, Deistung A, Goessler W, Scheurer E, Sommer K, Reishofer G, Yen K, Fazekas F, Ropele S, Reichenbach JR (2012) Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. NeuroImage 62(3):1593–1599. https://doi.org/10.1016/j.neuroimage.2012.05.049 CrossRefPubMedPubMedCentral

22.

Lin PY, Chao TC, ML W (2015) Quantitative susceptibility mapping of human brain at 3T: a multisite reproducibility study. AJNR Am J Neuroradiol 36(3):467–474. https://doi.org/10.3174/ajnr.A4137 CrossRefPubMed

23.

Turner MR, Kiernan MC, Leigh PN, Talbot K (2009) Biomarkers in amyotrophic lateral sclerosis. Lancet Neurology 8(1):94–109. https://doi.org/10.1016/S1474-4422(08)70293-X CrossRefPubMed

24.

Ignjatovic A, Stevic Z, Lavrnic S, Dakovic M, Bacic G (2013) Brain iron MRI: a biomarker for amyotrophic lateral sclerosis. J magnetic resonance imaging : JMRI 38(6):1472–1479. https://doi.org/10.1002/jmri.24121 CrossRefPubMed

25.

Karaarslan E, Arslan A (2003) Perirolandic cortex of the normal brain: low signal intensity on turbo FLAIR MR images. Radiology 227(2):538–541. https://doi.org/10.1148/radiol.2272020311 CrossRefPubMed

26.

Waragai M (1997) MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology 39(12):847–851CrossRefPubMed

27.

Cosottini M, Donatelli G (2016) High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 37(3):455–461. https://doi.org/10.3174/ajnr.A4562 CrossRefPubMed

28.

Oba H, Araki T, Ohtomo K, Monzawa S, Uchiyama G, Koizumi K, Nogata Y, Kachi K, Shiozawa Z, Kobayashi M (1993) Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 189(3):843–846. https://doi.org/10.1148/radiology.189.3.8234713 CrossRefPubMed

29.

Cheung G, Gawel MJ, Cooper PW, Farb RI, Ang LC, Gawal MJ (1995) Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 194(1):263–270. https://doi.org/10.1148/radiology.194.1.7997565 CrossRefPubMed

30.

Hirai T, Korogi Y, Sakamoto Y, Hamatake S, Ikushima I, Takahashi M (1996) T2 shortening in the motor cortex: effect of aging and cerebrovascular diseases. Radiology 199(3):799–803. https://doi.org/10.1148/radiology.199.3.8638008 CrossRefPubMed

31.

Korogi Y, Hirai T, Komohara Y, Okuda T, Ikushima I, Kitajima M, Shigematu Y, Sugahara T, Takahashi M (1997) T2 shortening in the visual cortex: effect of aging and cerebrovascular disease. AJNR Am J Neuroradiol 18(4):711–714PubMed

32.

Kakeda S, Yoneda T, Ide S, Miyata M, Hashimoto T, Futatsuya K, Watanabe K, Ogasawara A, Moriya J, Sato T, Okada K, Uozumi T, Adachi H, Korogi Y (2016) Zebra sign of precentral gyri in amyotrophic lateral sclerosis: a novel finding using phase difference enhanced (PADRE) imaging-initial results. Eur Radiol 26(11):4173–4183. https://doi.org/10.1007/s00330-016-4219-4 CrossRefPubMed

33.

Costagli M, Donatelli G, Biagi L, Caldarazzo Ienco E, Siciliano G, Tosetti M, Cosottini M (2016) Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. NeuroImage Clinical 12:965–969. https://doi.org/10.1016/j.nicl.2016.04.011 CrossRefPubMedPubMedCentral

34.

Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3(1):41–51CrossRefPubMed

35.

Prell T, Hartung V, Tietz F, Penzlin S, Ilse B, Schweser F, Deistung A, Bokemeyer M, Reichenbach JR, Witte OW, Grosskreutz J (2015) Susceptibility-weighted imaging provides insight into white matter damage in amyotrophic lateral sclerosis. PLoS One 10(6):e0131114. https://doi.org/10.1371/journal.pone.0131114 CrossRefPubMedPubMedCentral

36.

Smith MC (1960) Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 23(4):269–282CrossRefPubMedPubMedCentral

37.

Turner MR, Agosta F, Bede P, Govind V, Lule D, Verstraete E (2012) Neuroimaging in amyotrophic lateral sclerosis. Biomark Med 6(3):319–337. https://doi.org/10.2217/bmm.12.26 CrossRefPubMed

38.

Kolind S, Sharma R, Knight S, Johansen-Berg H, Talbot K, Turner MR (2013) Myelin imaging in amyotrophic and primary lateral sclerosis. Amyotrophic Lateral Sclerosis Frontotemporal Degeneration 14(7–8):562–573. https://doi.org/10.3109/21678421.2013.794843 CrossRefPubMedPubMedCentral

39.

Li X, Harrison DM, Liu H, Jones CK, Oh J, Calabresi PA, van Zijl PC (2016) Magnetic susceptibility contrast variations in multiple sclerosis lesions. J magnetic resonance imaging : JMRI 43(2):463–473. https://doi.org/10.1002/jmri.24976 CrossRefPubMed

40.

Li W, Wu B, Avram AV, Liu C (2012) Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings. NeuroImage 59(3):2088–2097. https://doi.org/10.1016/j.neuroimage.2011.10.038 CrossRefPubMed

41.

Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N, Hampel H, Gallagher L, Lynch C, Fagan AJ, Pender N, Hardiman O (2013) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 84(7):766–773. https://doi.org/10.1136/jnnp-2012-302674 CrossRefPubMed

Titel: Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls
verfasst von: Ji Young Lee
Young-Jun Lee
Dong Woo Park
Yoonho Nam
Seung Hyun Kim
Jinseok Park
Young Seo Kim
Hyun Young Kim
Ki-Wook Oh
Publikationsdatum: 11.10.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Neuroradiology / Ausgabe 12/2017
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI: https://doi.org/10.1007/s00234-017-1933-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls